Post-Implant Performance of the EC-3 IOL

Status unconfirmed

Conditions studied: Cataract

In brief

The purpose of this study is to obtain data on the performance of the EC-3 lens at an interval of two years (and beyond) from subjects who were implanted. The primary aim of the study will be to evaluate the presence, if any, of PCO, lens glistening, and other anomalies in the subjects.

Key facts

Study ID

NCT01333345

Run by

Aaren Scientific Inc.

People needed

100

Starts

2011-04-01

Expected to finish

2011-06-01

Last updated by the study team

2011-04-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Enrollment in the EC-3 clinical trial
• Subjects who were implanted with EC-3 IOL

You may not qualify if…

• Removal of the EC-3 IOL at any time

Where it is running

• Stephenson Eye Associates — Venice, Florida, United States
• Eyesight Ophthalmic Services — Dover, New Hampshire, United States
• Cabinet d'Ophtalmologie du Dr. Pey — Le Puy-en-Velay, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.